Dose Escalation Study Evaluating Safety of TheraSphere Prostate Cancer (PCa) Device

NCT06192758 · clinicaltrials.gov ↗

NA

Phase

ACTIVE_NOT_RECRUITING

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Prostate
Cancer

Interventions

DEVICE: TheraSphere PCa

Sponsor

Boston Scientific Corporation